According to a research report titled ‘Global External Ventricular Drain Market Size study, by Application (Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Other Non-Traumatic Hydrocephalus Conditions) and Regional Forecasts 2020-2027’, available with Market Study Report, global external ventricular drain market was valued at USD 5.3 billion in 2019 and is expected to record 7.6% CAGR, reaching a valuation of USD 9.5 billion by the year 2027.
 

As per report findings, increased cases of brain injuries attributable to road accidents, rise in prevalence of neurological disorders, proactive government initiatives, and adoption of technologically advanced infrastructure are major factors determining the growth of worldwide external ventricular drain industry. According to Stroke Statistics 2018, over 100,000 individuals endure strokes each year in the United Kingdom, of which 85% are ischemic strokes and 15% are hemorrhagic. These statistics further imply strengthening demand in the market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3002314/
 

For the uninitiated, external ventricular drain (EVD), also known as extraventricular drain is a tool vital in neurosurgery. The device is used to drain excess cerebrospinal fluid to relieve elevated intracranial pressure. Ventricular drainage sets can be used to treat several medical conditions such as intraventricular hemorrhages, inflammatory conditions in the cerebrospinal space, closed head injuries, intracranial hypertension or subarachnoid and transient occlusive hydrocephalus. Moreover, the kit includes a catheter, drainage bag, and monitor that help in treatment of various medical conditions, which is expected to stimulate external ventricular drain market remuneration over the forecast period.
 

However, ventricular drainage or ventriculostomy is a complex procedure, and involves complicated regulatory frameworks for product approval, which may result in slow market growth in the ensuing years.
 

Based on application ambit, global external ventricular drain industry is arrayed into intracerebral hemorrhage, subarachnoid hemorrhage, traumatic brain Injury, and other non-traumatic hydrocephalus conditions.
 

On the regional front, North America is leading in terms of market share currently, owing to rising prevalence of neurovascular disorders and traumatic brain injuries, along with a presence of substantial number of suppliers in the region.
 

Meanwhile, Asia Pacific external ventricular drain market size is projected to record the highest CAGR during 2020-2027, due to increasing cases of brain injuries, and rapid development of healthcare infrastructure in countries such as China as well as India.
 

Key contenders in worldwide external ventricular drain market are Integra LifeSciences Holdings Corporation, Spiegelberg Gmbh & Co. KG, B. Braun Melsungen AG, Medtronic plc, Fuji Systems Corporation, Sophysa, Möller Medical GmbH, and Dispomedica GmbH.